Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes.

Casanova N, Zhou T, Gonzalez-Garay ML, Rosas IO, Goldberg HJ, Ryter SW, Collard HR, El-Chemaly S, Flaherty KR, Hunninghake GM, Lasky JA, Lederer DJ, Machado RF, Martinez FJ, Noth I, Raghu G, Choi AMK, Garcia JGN.

Sci Rep. 2019 Oct 15;9(1):14802. doi: 10.1038/s41598-019-50585-3.

2.

Risk factors for disease progression in idiopathic pulmonary fibrosis.

Raghu G, Ley B, Brown KK, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Noble PW, Song JW, Wells AU, Whelan TP, Lynch DA, Humphries SM, Moreau E, Goodman K, Patterson SD, Smith V, Gong Q, Sundy JS, O'Riordan TG, Martinez FJ.

Thorax. 2019 Oct 14. pii: thoraxjnl-2019-213620. doi: 10.1136/thoraxjnl-2019-213620. [Epub ahead of print]

PMID:
31611341
3.

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.

Collins BF, Raghu G.

Eur Respir Rev. 2019 Oct 1;28(153). pii: 190022. doi: 10.1183/16000617.0022-2019. Print 2019 Sep 30. Review.

4.

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.

Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, Mahar A, Myers JL, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Jo HE, Webster SE, Lin QT, Rhodes JE, Salamonsen M, Wrobel JP, Harris B, Don G, Wu PJC, Ng BJ, Oldmeadow C, Raghu G, Lau EMT; Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease alliance (COLDICE) Investigators.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30342-X. doi: 10.1016/S2213-2600(19)30342-X. [Epub ahead of print]

PMID:
31578168
5.

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.

Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30262-0. doi: 10.1016/S2213-2600(19)30262-0. [Epub ahead of print]

PMID:
31575509
6.

Severe Silicosis in Engineered Stone Fabrication Workers - California, Colorado, Texas, and Washington, 2017-2019.

Rose C, Heinzerling A, Patel K, Sack C, Wolff J, Zell-Baran L, Weissman D, Hall E, Sooriash R, McCarthy RB, Bojes H, Korotzer B, Flattery J, Weinberg JL, Potocko J, Jones KD, Reeb-Whitaker CK, Reul NK, LaSee CR, Materna BL, Raghu G, Harrison R.

MMWR Morb Mortal Wkly Rep. 2019 Sep 27;68(38):813-818. doi: 10.15585/mmwr.mm6838a1.

7.

Idiopathic pulmonary fibrosis: shifting the concept to irreversible pulmonary fibrosis of many entities.

Raghu G.

Lancet Respir Med. 2019 Sep 13. pii: S2213-2600(19)30311-X. doi: 10.1016/S2213-2600(19)30311-X. [Epub ahead of print] No abstract available.

PMID:
31530469
8.

The 2018 Diagnosis of IPF Guidelines: Surgical Lung Biopsy in Probable UIP is Not Mandatory.

Raghu G, Remy-Jardin M, Myers J, Richeldi L, Wilson KC.

Am J Respir Crit Care Med. 2019 Sep 9. doi: 10.1164/rccm.201907-1324ED. [Epub ahead of print] No abstract available.

PMID:
31498684
9.

Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

McGroder CF, Aaron CP, Bielinski SJ, Kawut SM, Tracy RP, Raghu G, Barr RG, Lederer DJ, Podolanczuk AJ.

Eur Respir J. 2019 Sep 30;54(3). pii: 1900295. doi: 10.1183/13993003.00295-2019. Print 2019 Sep.

PMID:
31371443
10.

Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study.

Gannon WD, Anderson MR, Podolanczuk AJ, Kawut SM, Michos ED, Cottin V, Kreuter M, Raghu G, Barr RG, Lederer DJ.

Ann Am Thorac Soc. 2019 Jul 31. doi: 10.1513/AnnalsATS.201903-198RL. [Epub ahead of print] No abstract available.

PMID:
31365837
11.

Endoplasmic reticulum stress: A master regulator of metabolic syndrome.

Mohan S, R PRM, Brown L, Ayyappan P, G RK.

Eur J Pharmacol. 2019 Oct 5;860:172553. doi: 10.1016/j.ejphar.2019.172553. Epub 2019 Jul 17. Review.

PMID:
31325433
12.

Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study.

Troy LK, Grainge C, Corte T, Williamson JP, Vallely MP, Cooper W, Mahar AM, Lai S, Mulyadi E, Torzillo PJ, Salamonsen M, Don G, Myers J, Raghu G, Lau EMT; COLDICE Investigator Team.

BMJ Open Respir Res. 2019 Jun 21;6(1):e000443. doi: 10.1136/bmjresp-2019-000443. eCollection 2019.

13.

Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.

Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, Poletti V, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown KK, Corte TJ, Cottin V, Crestani B, Flaherty KR, Glaspole IN, Grutters J, Inoue Y, Kondoh Y, Kreuter M, Johannson KA, Ley B, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts WA, Wells AU.

Am J Respir Crit Care Med. 2019 Jun 26. doi: 10.1164/rccm.201903-0493OC. [Epub ahead of print]

14.

Hypersensitivity Pneumonitis: Current Concepts of Pathogenesis and Potential Targets for Treatment.

Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, Raghu G.

Am J Respir Crit Care Med. 2019 Aug 1;200(3):301-308. doi: 10.1164/rccm.201903-0541PP. No abstract available.

PMID:
31150272
15.

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.

Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L.

Lancet Respir Med. 2019 Aug;7(8):657-664. doi: 10.1016/S2213-2600(19)30172-9. Epub 2019 May 20.

PMID:
31122893
16.

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators.

N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20.

PMID:
31112379
17.

Sarcoidosis and idiopathic pulmonary fibrosis: The same tale or a tale of two diseases in one.

Collins BF, Raghu G.

Respir Med. 2019 Apr 1. pii: S0954-6111(19)30096-4. doi: 10.1016/j.rmed.2019.03.021. [Epub ahead of print] No abstract available.

PMID:
30975546
18.

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.

Raghu G, Flaherty KR, Lederer DJ, Lynch DA, Colby TV, Myers JL, Groshong SD, Larsen BT, Chung JH, Steele MP, Benzaquen S, Calero K, Case AH, Criner GJ, Nathan SD, Rai NS, Ramaswamy M, Hagmeyer L, Davis JR, Gauhar UA, Pankratz DG, Choi Y, Huang J, Walsh PS, Neville H, Lofaro LR, Barth NM, Kennedy GC, Brown KK, Martinez FJ.

Lancet Respir Med. 2019 Jun;7(6):487-496. doi: 10.1016/S2213-2600(19)30059-1. Epub 2019 Apr 1.

PMID:
30948346
19.

Cryobiopsy for Interstitial Lung Disease: The Heat Is On.

Raghu G, Lederer DJ, Rabe KF.

Am J Respir Crit Care Med. 2019 May 15;199(10):1183-1184. doi: 10.1164/rccm.201903-0682ED. No abstract available.

20.

Idiopathic Pulmonary Fibrosis Guideline Recommendations. Need for Adherence to Institute of Medicine Methodology?

Wilson KC, Schoenberg NC, Raghu G.

Ann Am Thorac Soc. 2019 Jun;16(6):681-686. doi: 10.1513/AnnalsATS.201812-871OC.

PMID:
30810336
21.

Surgical lung biopsy for interstitial lung disease: when considered necessary, should these be done in larger and experienced centres only?

Hutchinson J, Hubbard R, Raghu G.

Eur Respir J. 2019 Feb 21;53(2). pii: 1900023. doi: 10.1183/13993003.00023-2019. Print 2019 Feb. No abstract available.

PMID:
30792236
22.

Diagnosis of idiopathic pulmonary fibrosis by virtual means using "IPFdatabase"- a new software.

Bennett D, Mazzei MA, Collins B, Bargagli E, Pipavath S, Spina D, Valentini ML, Rinaldi C, Bettini G, Ginori A, Refini RM, Rottoli P, Raghu G.

Respir Med. 2019 Feb;147:31-36. doi: 10.1016/j.rmed.2018.12.011. Epub 2019 Jan 3.

PMID:
30704696
23.

Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis.

Brown KK, Flaherty KR, Cottin V, Raghu G, Inoue Y, Azuma A, Huggins JT, Richeldi L, Stowasser S, Stansen W, Schlenker-Herceg R, Maher TM, Wells AU.

Respir Med. 2019 Jan;146:42-48. doi: 10.1016/j.rmed.2018.11.012. Epub 2018 Nov 19.

PMID:
30665517
24.

Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.

Cottin V, Azuma A, Raghu G, Stansen W, Stowasser S, Schlenker-Herceg R, Kolb M.

Eur Respir J. 2019 Apr 18;53(4). pii: 1801655. doi: 10.1183/13993003.01655-2018. Print 2019 Apr. No abstract available.

PMID:
30655282
25.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

QJM. 2019 Feb 1;112(2):81-93. doi: 10.1093/qjmed/hcy272. No abstract available.

PMID:
30605544
26.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

Arthritis Rheumatol. 2019 Feb;71(2):182-195. doi: 10.1002/art.40769. Epub 2019 Jan 3. No abstract available.

PMID:
30604506
27.

Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.

Newton CA, Zhang D, Oldham JM, Kozlitina J, Ma SF, Martinez FJ, Raghu G, Noth I, Garcia CK.

Am J Respir Crit Care Med. 2019 Aug 1;200(3):336-347. doi: 10.1164/rccm.201809-1646OC.

PMID:
30566847
28.

Reply to Moodley and to Ravaglia et al.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Wilson K.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):667-669. doi: 10.1164/rccm.201810-2006LE. No abstract available.

PMID:
30566844
29.

2018 Clinical Practice Guideline Summary for Clinicians: Diagnosis of Idiopathic Pulmonary Fibrosis.

Thomson CC, Duggal A, Bice T, Lederer DJ, Wilson KC, Raghu G.

Ann Am Thorac Soc. 2019 Mar;16(3):285-290. doi: 10.1513/AnnalsATS.201809-604CME. No abstract available.

PMID:
30543449
30.

Palliative care for patients with pulmonary fibrosis: symptom relief is essential.

Lindell K, Raghu G.

Eur Respir J. 2018 Dec 6;52(6). pii: 1802086. doi: 10.1183/13993003.02086-2018. Print 2018 Dec. No abstract available.

PMID:
30523209
31.

Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.

Raghu G, Richeldi L, Jagerschmidt A, Martin V, Subramaniam A, Ozoux ML, Esperet CA, Soubrane C.

Chest. 2018 Dec;154(6):1359-1370. doi: 10.1016/j.chest.2018.08.1083.

PMID:
30526970
32.

Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors.

Sack C, Raghu G.

Eur Respir J. 2019 Feb 21;53(2). pii: 1801699. doi: 10.1183/13993003.01699-2018. Print 2019 Feb.

PMID:
30487201
33.

Hypersensitivity pneumonitis and its correlation with ambient air pollution in urban India.

Singh S, Collins BF, Bairwa M, Joshi JM, Talwar D, Singh N, Samaria JK, Mangal DK, Singh V, Raghu G.

Eur Respir J. 2019 Jan 31;53(2). pii: 1801563. doi: 10.1183/13993003.01563-2018. Print 2019 Feb. No abstract available.

PMID:
30464015
34.

Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes.

Ebrahimpour A, Shrestha S, Bonnen MD, Eissa NT, Raghu G, Ghebre YT.

J Pharmacol Exp Ther. 2019 Feb;368(2):169-178. doi: 10.1124/jpet.118.252650. Epub 2018 Nov 16.

PMID:
30446578
35.

Response to Letter to Editor regarding "Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?"

Collins BF, Raghu G.

Respir Med. 2019 Mar;149:43-44. doi: 10.1016/j.rmed.2018.10.029. Epub 2018 Oct 27. No abstract available.

PMID:
30389206
36.

SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772).

Raghu G, Richeldi L, Crestani B, Wung P, Bejuit R, Esperet C, Antoni C, Soubrane C.

Eur Respir J. 2018 Dec 13;52(6). pii: 1801130. doi: 10.1183/13993003.01130-2018. Print 2018 Dec.

PMID:
30337444
37.

Cardiac sarcoidosis: Diagnosis confirmation by bronchoalveolar lavage and lung biopsy.

Petek BJ, Rosenthal DG, Patton KK, Behnia S, Keller JM, Collins BF, Cheng RK, Ho LA, Bravo PE, Mikacenic C, Raghu G.

Respir Med. 2018 Nov;144S:S13-S19. doi: 10.1016/j.rmed.2018.09.008. Epub 2018 Sep 16.

PMID:
30249376
38.

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.

Kolb M, Raghu G, Wells AU, Behr J, Richeldi L, Schinzel B, Quaresma M, Stowasser S, Martinez FJ; INSTAGE Investigators.

N Engl J Med. 2018 Nov 1;379(18):1722-1731. doi: 10.1056/NEJMoa1811737. Epub 2018 Sep 15.

PMID:
30220235
39.

Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies.

Richeldi L, Wilson KC, Raghu G.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801485. doi: 10.1183/13993003.01485-2018. Print 2018 Sep. No abstract available.

PMID:
30190265
40.

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials.

Costabel U, Behr J, Crestani B, Stansen W, Schlenker-Herceg R, Stowasser S, Raghu G.

Respir Res. 2018 Sep 3;19(1):167. doi: 10.1186/s12931-018-0866-0.

41.

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendía-Roldán I, Selman M, Travis WD, Walsh S, Wilson KC; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.

PMID:
30168753
42.

Understanding the evolving phenotype of vascular complications in telomere biology disorders.

Higgs C, Crow YJ, Adams DM, Chang E, Hayes D Jr, Herbig U, Huang JN, Himes R, Jajoo K, Johnson FB, Reynolds SD, Yonekawa Y, Armanios M, Boulad F, DiNardo CD, Dufour C, Goldman FD, Khan S, Kratz C, Myers KC, Raghu G, Alter BP, Aubert G, Bhala S, Cowen EW, Dror Y, El-Youssef M, Friedman B, Giri N, Helms Guba L, Khincha PP, Lin TF, Longhurst H, McReynolds LJ, Nelson A, Olson T, Pariser A, Perona R, Sasa G, Schratz K, Simonetto DA, Townsley D, Walsh M, Stevens K, Agarwal S, Bertuch AA, Savage SA; Clinical Care Consortium for Telomere-associated Ailments (CCCTAA).

Angiogenesis. 2019 Feb;22(1):95-102. doi: 10.1007/s10456-018-9640-7. Epub 2018 Aug 25.

PMID:
30168024
43.

Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?

Collins BF, McClelland RL, Ho LA, Mikacenic CR, Hayes J, Spada C, Raghu G.

Respir Med. 2018 Nov;144S:S20-S27. doi: 10.1016/j.rmed.2018.08.008. Epub 2018 Aug 23.

PMID:
30166087
44.

Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis.

Humphries SM, Swigris JJ, Brown KK, Strand M, Gong Q, Sundy JS, Raghu G, Schwarz MI, Flaherty KR, Sood R, O'Riordan TG, Lynch DA.

Eur Respir J. 2018 Sep 17;52(3). pii: 1801384. doi: 10.1183/13993003.01384-2018. Print 2018 Sep.

PMID:
30139770
45.

Accuracy of Digital Tomosynthesis of the Chest in Detection of Interstitial Lung Disease Comparison With Digital Chest Radiography.

Kruamak T, Edwards R, Cheng S, Hippe DS, Raghu G, Pipavath SNJ.

J Comput Assist Tomogr. 2019 Jan/Feb;43(1):109-114. doi: 10.1097/RCT.0000000000000780.

PMID:
30119061
46.

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.

Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR.

Lancet Respir Med. 2018 Sep;6(9):707-714. doi: 10.1016/S2213-2600(18)30301-1. Epub 2018 Aug 9.

PMID:
30100404
47.

Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation.

Rosenthal DG, Anderson ME, Petek BJ, Arnett DM, Bravo PE, Raghu G, Goldberger ZD, Patton KK, Cheng RK.

Can J Cardiol. 2018 Aug;34(8):978-982. doi: 10.1016/j.cjca.2018.03.021. Epub 2018 Apr 6.

PMID:
30049365
48.

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.

Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF.

Am J Respir Crit Care Med. 2019 Jan 1;199(1):12-21. doi: 10.1164/rccm.201803-0444PP. No abstract available.

49.

Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.

Madahar P, Duprez DA, Podolanczuk AJ, Bernstein EJ, Kawut SM, Raghu G, Barr RG, Gross MD, Jacobs DR Jr, Lederer DJ.

Respir Med. 2018 Jul;140:108-114. doi: 10.1016/j.rmed.2018.06.001. Epub 2018 Jun 6.

50.

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent.

Kreuter M, Raghu G.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800921. doi: 10.1183/13993003.00921-2018. Print 2018 Jun. No abstract available.

PMID:
29929960

Supplemental Content

Loading ...
Support Center